Officer exercised or converted 2,200 CYTK derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 18, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 18, 2025
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001061983-25-000037
Added to OQROOct 6, 2026, 7:14 PM UTC Data qualityVerified: identifiers matched exactly Reporting personFady Ibraham Malik Officer titleEVP Research & Development TableNon-derivative (Table I) Transaction dateNov 18, 2025 Acquired / disposedAcquired (A) Shares owned after142,810 Around the same time
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$135K of Cytokinetics
Automatic saleDerivative exercise or conversion — not an open-market buy.